All good, I can change my statement to BMT-CTN will cover most of the trial costs.
Mesoblast will only pay 6-9mil for their share of the Adult aGHVD trial.
Peanuts for Mesoblast's share of costs to achieve a full trial and plenty of money still left in the bank after 6 to 9 mil cost.
I agree with you that Si believes there is also more cash coming in soonish - next 6 months from some type partnership/commercial sales transaction(s). Bring that on.
Si did seem to have a lot of confidence today on the company progression and achievements of these trials completing.
All good, I can change my statement to BMT-CTN will cover most...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |